From Rs 42 to Rs 238 - This realty stock is running a MARATHON!

From Rs 42 to Rs 238 - This realty stock is running a MARATHON!

by 5paisa Research Team Last Updated: Dec 15, 2022 - 02:47 am 21k Views

MARATHON has soared nearly 5% in Tuesday’s trading session.

The stock of Marathon Nextgen Realty Ltd is the talk of the town lately, having soared over 200% in one year and has attracted traders’ attention. From its previous year’s low of Rs 42 in April, the stock has jumped to Rs 232 (over 550% gain) in just 15 months. Moreover, it soared nearly 5% on Tuesday’s trading session. With such a strong short as well as a long-term uptrend, the stock is all guns blazing!

The stock has hit a fresh 52-week high level of Rs 238 level and has also recorded above-average volume. The volume was found to be greater than the 10-day and 30-day average volume. Interestingly, the 20-DMA level has acted as strong support for the stock in the past few weeks, as the stock has seen strong buying interest at every dip. The 14-period daily RSI (60.88) is in the bullish territory and shows strong strength in the stock. Interestingly, the MACD has signalled a bullish crossover. The OBV continues to remain elevated amid strong buying interest and a surge in volumes. The Elder Impulse has charted a bullish chart, while TSI and KST indicators maintain their bullish view. Currently, the stock is about 7% above its 20-DMA and about 85% above its 200-DMA.

With such a strong price structure, along with bullish technical apartments, the stock is expected to continue its upside path. The stock is also bullish for the medium term from the above points. Traders can consider taking positions in this stock at every dip and can expect good gains in the near term.

Marathon Nextgen Realty Limited is a real estate company, working in the construction, development, and sale of commercial as well as residential real estate projects. With a market capitalization of over Rs 1000 crore, it is one of the strong growing real estate companies.

Share Market Today

How do you rate this article?


Start Investing in 5 mins*

Rs. 20 Flat Per Order | 0% Brokerage


About the Author

Our research team is composed of some highly qualified research professionals, their expertise range across sectors.


Investment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial.
Open Free Demat Account
Resend OTP
Please Enter OTP
Account belongs to

By proceeding, you agree to the T&C.

Latest News
BSE to Discontinue Stop Loss Market Orders for All Segments from October 9

Bombay Stock Exchange (BSE) has announced the discontinuation of Stop Loss Market (SL-M) orders, effective from October 9. This decision follows a recent incident involving a "freak trade" triggered by an SL-M order, which led to concerns within the trading community. The aim is to prevent erroneous order placements, whether they result from manual or algorithmic trading.

  • Oct 03, 2023
Valiant Laboratories IPO: Closing subscription details

Valiant Laboratories Ltd has a face value of ₹10 per share while the price band for the book building IPO has been set in the band of ₹133 to ₹140 per share. The final price will be discovered within this band, through the process of book building. The fresh issue portion entailed the issue of 1,08,90,000 shares (108.90 lakh shares), which at the upper price band of ₹140 per share will translate into fresh issue size of ₹152.46 crore.

  • Oct 03, 2023
Saakshi Medtech IPO: Listing day Update

Premium listing for Saakshi Medtech and Panels Ltd, then hits upper circuit Saakshi Medtech and Panels Ltd had a strong listing on 03rd October 2023, listing at a premium of 50.52%, and subsequently hitting the 5% upper circuit on

  • Oct 03, 2023